Strain | Action | Reference |
Lactobacillus | Significant decrease in gastrointestinal symptoms, including nausea, postprandial fullness, and gastrointestinal pain | [36] |
Lactobacillus | Decreased inflammation related to H. Pylori | [36] |
Lactobacillus | Relief of symptoms of lactose intolerance, cholesterol reduction | [37] |
Sacharomyces boulardii | Anti-inflammatory activity | [38] |
Saccharomyces boulardii | Recommended for the treatment of acute gastrointestinal diseases, such as rotaviral and bacterial diarrhea and chronic conditions, such as inflammatory bowel disease | [39] |
Lactobacillus acidophilus | Changes in the profile of inflammatory cytokine production and regulation of proinflammatory pathways, inhibition of the adhesion of pathogenic bacteria, modification of the microbiota by acidification of the colon due to fermenting agents, improvement in the function of the epithelial barrier, and protection against physiological stress | [40] |
Bifidobacterium longum | Associated with carbohydrate metabolism | [41] |
Bifidobacterium longum | Protection against autoimmune diseases such as inflammatory bowel disease, metabolic syndromes, irritable bowel syndrome colitis and brain disorders | [41] |
Lacticaseibacillus rhamnosus | Beneficial for vaginal and postpartum female health | [42] |
Lactobacillus acidophilus | Decrease in toxins produced by the kidneys | [43] |